Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Emily Melton
AddedMar 31, 2024
UpdatedJun 28, 2026
Emily Melton

Emily Melton

Board Member, Verge Genomics

CrunchbaseLinkedIn

Emily Melton's Career

Verge Genomics
Verge Genomics

San Francisco, CA, US

Board Member· Board
Vineti
Vineti

San Francisco, CA, US

Board Member· Board
Elation Health
Elation Health

San Francisco, CA, US

Board Member· Board
Brightline
Brightline

Palo Alto, CA, US

Board Member· Board
BetterUp
BetterUp

San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Emily Melton's Career

Verge Genomics
Verge Genomics
Series B$134.1M832015San Francisco, CA, US
Board Member· Board

Leadership at Verge Genomics

Mario SaltarelliMario SaltarelliBoard Member
Gwen MelincoffGwen MelincoffBoard Member
Alice ZhangAlice ZhangFounder & CEO
Alfred SandrockAlfred SandrockBoard Member
Jason ChenJason ChenCo-Founder
Andrew R. AllenAndrew R. AllenBoard Member
Vineti
Vineti
Series C$115.3M3752016San Francisco, CA, US
Board Member· Board

Recent news

a16z-backed Rooms.xyz lets you build interactive, 3D rooms and simple games in your browserTechCrunch · 2023

Leadership at Vineti

Eli CasdinEli CasdinBoard Member
Stephen TingStephen TingCo-Founder
Amy DurossAmy DurossCo-Founder
Heidi HagenHeidi HagenCo-Founder
Nina KjellsonNina KjellsonBoard Member
Ann KleinAnn KleinCEO

Similar to Vineti

Vita TherapeuticsVita TherapeuticsBaltimore, MD, USCell Therapiesest. 2018Vita TherapeuticsBaltimore, MD, US · est. 2018

Vita Therapeutics: Pioneering life-transformative treatments through cell engineering.

Series B · $63M33
ViTToria BiotherapeuticsViTToria BiotherapeuticsPhiladelphia, PA, USCell Therapiesest. 2021ViTToria BiotherapeuticsPhiladelphia, PA, US · est. 2021

Vittoria Biotherapeutics pioneers in gene-edited T-cell therapies, enhancing efficacy and safety in cell-based treatments.

Series B · $25M34
VintaBioVintaBioPhiladelphia, PA, USViral Vectorsest. 2020VintaBioPhiladelphia, PA, US · est. 2020

VintaBio: Expert CDMO provider for viral vectors, advancing cell and gene therapy manufacturing.

Series D · $64M15
Endpoint HealthEndpoint HealthPalo Alto, CA, USTests, Therapeuticsest. 2018Endpoint HealthPalo Alto, CA, US · est. 2018

Endpoint Health: Personalized therapies for immune-driven illnesses, improving patient outcomes.

Series D · $64.2M
Elation Health
Elation Health
Series D$108.5M2792010San Francisco, CA, US
Board Member· Board

Leadership at Elation Health

Conan FongConan FongCo-Founder
Kyna FongKyna FongCo-Founder
Albert KoAlbert KoBoard Member
Brightline
Brightline
Series C$212M2702019Palo Alto, CA, US
Board Member· Board

Leadership at Brightline

Giovanni ColellaGiovanni ColellaBoard Member
Annie LamontAnnie LamontBoard Member
Johnny KimJohnny KimBoard Member
Ben RobbinsBen RobbinsBoard Member
Naomi AllenNaomi AllenCo-Founder

Similar to Brightline

Lyra HealthLyra HealthBurlingame, CA, USHealthcare, Mental Healthest. 2015Lyra HealthBurlingame, CA, US · est. 2015

Lyra Health, a California-based medical organization, revolutionizes global behavioral healthcare through technology.

Series F · $910.1M2.4k
Foresight Mental HealthForesight Mental HealthBerkeley, CA, USMental Health, Telemedicineest. 2018Foresight Mental HealthBerkeley, CA, US · est. 2018

Foresight: A virtual care provider leveraging technology for mental health services.

Series C356
BrightlifeBrightlifeBowling Green, KY, USMental Healthest. 2021BrightlifeBowling Green, KY, US · est. 2021

Brightlife Flow: A comprehensive SaaS platform enhancing mental health care efficiency with treatment tracking and customer management.

Pre-Seed · $50k6
aptihealthaptihealthTroy, NY, USBehavioral Healthest. 2017aptihealthTroy, NY, US · est. 2017

aptihealth, inc. integrates physical and behavioral healthcare, connecting providers and patients.

Series B · $65M97
BetterUp
BetterUp
Series E$569.8M7502013San Francisco, CA, US
Board Member· Board

Leadership at BetterUp

Eddie MedinaEddie MedinaCo-Founder
Gabriella Rosen KellermanGabriella Rosen KellermanBoard Member
Alexi RobichauxAlexi RobichauxCo-Founder
David HatfieldDavid HatfieldBoard Member
Fred KofmanFred KofmanBoard Member
Ellen LevyEllen LevyBoard Member

Emily Melton's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Emily Melton

Andreas StavropoulosAndreas StavropoulosBoard Member · AkimboSam FortSam FortBoard Member · Ping IdentityJohn EltonJohn EltonBoard Member · Rapid RoboticsAlison Lange EngelAlison Lange EngelInvestor · PublicMike VernalMike VernalGeneral Partner · Conviction PartnersIlya FushmanIlya FushmanBoard Member · Welcome